Clinical Trial Update: Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial update indicates empagliflozin is being studied to improve right ventricular function in pulmonary arterial hypertension and is currently enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Gustavo A Heresi, MD, MS | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: ENROLLING_BY_INVITATION